Inactivation of 3-hydroxybutyrate dehydrogenase type 2 promotes proliferation and metastasis of nasopharyngeal carcinoma by iron retention
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inactivation of 3-hydroxybutyrate dehydrogenase type 2 promotes proliferation and metastasis of nasopharyngeal carcinoma by iron retention
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 122, Issue 1, Pages 102-110
Publisher
Springer Science and Business Media LLC
Online
2019-12-10
DOI
10.1038/s41416-019-0638-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Obesity Protects Cancer from Drugs Targeting Blood Vessels
- (2018) Yihai Cao Cell Metabolism
- Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance
- (2018) Hideki Iwamoto et al. Cell Metabolism
- Increased B3GALNT2 in hepatocellular carcinoma promotes macrophage recruitment via reducing acetoacetate secretion and elevating MIF activity
- (2018) Tianxiao Yang et al. Journal of Hematology & Oncology
- Interplay of the iron-regulated metastasis suppressor NDRG1 with epidermal growth factor receptor (EGFR) and oncogenic signaling
- (2017) Sharleen V. Menezes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metals and metastasis: Exploiting the role of metals in cancer metastasis to develop novel anti-metastatic agents
- (2017) Leyla Fouani et al. PHARMACOLOGICAL RESEARCH
- Curcumin induces apoptosis and protective autophagy in castration-resistant prostate cancer cells through iron chelation
- (2017) Chunguang Yang et al. Drug Design Development and Therapy
- Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo
- (2016) Hirofumi Harima et al. BMC CANCER
- Cancer Metabolism: Fueling More than Just Growth
- (2016) Namgyu Lee et al. MOLECULES AND CELLS
- Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma
- (2016) Issei Saeki et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Oncogenic regulation of tumor metabolic reprogramming
- (2016) Míriam Tarrado-Castellarnau et al. Oncotarget
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- Addicted to AA (Acetoacetate): A Point of Convergence between Metabolism and BRAF Signaling
- (2015) Sebastian Trousil et al. MOLECULAR CELL
- Iron metabolism: a double-edged sword in the resistance of glioblastoma to therapies
- (2015) Claire Legendre et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- 3-Hydroxybutyrate dehydrogenase-2 and ferritin-H synergistically regulate intracellular iron
- (2014) Zhuoming Liu et al. FEBS Journal
- Endogenous Siderophore 2,5-Dihydroxybenzoic Acid Deficiency Promotes Anemia and Splenic Iron Overload in Mice
- (2014) Z. Liu et al. MOLECULAR AND CELLULAR BIOLOGY
- Neisseria gonorrhoeae Modulates Iron-Limiting Innate Immune Defenses in Macrophages
- (2014) Susu M. Zughaier et al. PLoS One
- Inflammation and ER Stress Downregulate BDH2 Expression and Dysregulate Intracellular Iron in Macrophages
- (2014) Susu M. Zughaier et al. Journal of Immunology Research
- Development of artemisinin compounds for cancer treatment
- (2012) Henry C. Lai et al. INVESTIGATIONAL NEW DRUGS
- Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy
- (2011) Gabriele D Maurer et al. BMC CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Development and applications of a nasopharyngeal carcinoma Tet-Off cell line
- (2011) YU-PENG FENG et al. Oncology Letters
- A Mammalian Siderophore Synthesized by an Enzyme with a Bacterial Homolog Involved in Enterobactin Production
- (2010) Laxminarayana R. Devireddy et al. CELL
- Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis
- (2010) Z. K. Pinnix et al. Science Translational Medicine
- Role of iron in carcinogenesis: Cancer as a ferrotoxic disease
- (2009) Shinya Toyokuni CANCER SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started